Risk adjustment has always been a data-intensive discipline. But the scale, complexity, and regulatory pressure surrounding it in 2026 has made the limitations of manual processes impossible to ignore. Health plans managing Medicare Advantage populations are facing a convergence of forces that have fundamentally changed what effective risk adjustment looks like and what it demands from the technology behind it.
CMS confirmed in January 2026 that federal estimates point to approximately $17 billion in annual overpayments from unsupported diagnosis data submitted by Medicare Advantage organisations. That figure alone signals the shift that is already underway. Risk adjustment is no longer simply a revenue function. It is a compliance discipline, and the tools health plans use to manage it need to reflect that reality.
The Problem With Manual Chart Review
For years, the standard approach to risk adjustment relied heavily on human coders working through clinical documentation record by record. A complex chart review took between 30 and 45 minutes. Accuracy dropped during extended coding sessions. Burnout was common among coding teams, and scaling programmes to match growing membership meant proportionally growing headcount.
The output of this process was also difficult to defend. Traditional manual review produced HCC code suggestions without clear evidence trails linking each diagnosis to specific clinical documentation. When CMS questioned a submitted code, health plans struggled to produce the traceable, MEAT-criteria-based justification that audit readiness demands.
Improving accuracy through manual processes alone is no longer a viable strategy. The volume of records, the complexity of the V28 HCC model now fully in effect, and the frequency of RADV audits that CMS has signalled for 2026 all require a fundamentally different approach.
Where AI Changes the Equation
Artificial intelligence addresses the core failures of manual risk adjustment at every stage of the workflow. But not all AI in healthcare delivers equally, and the distinction between traditional machine learning and more advanced architectures matters significantly in a compliance context.
Standard AI algorithms operate as opaque systems. They produce outputs without showing their reasoning, which creates exactly the kind of audit exposure health plans cannot afford in the current regulatory environment. A probability score is not a defensible evidence trail.
Neuro-Symbolic AI takes a different approach. By combining deep learning pattern recognition with structured clinical reasoning, it understands the clinical context behind a diagnosis rather than simply pattern-matching against historical data. It recognises that a metformin prescription paired with an elevated A1C indicates active diabetes management. It distinguishes between a family history of a condition and a currently active, treated diagnosis, a distinction that directly affects HCC assignment and risk scoring.
Critically, every suggested HCC code produced by a Neuro-Symbolic system links to specific evidence in the clinical record, creating a transparent audit trail that supports MEAT criteria documentation and withstands RADV scrutiny. This is the kind of explainability that compliance-first risk adjustment programmes require.
Retrospective HCC Coding at Scale
The productivity gains that AI delivers to retrospective risk adjustment workflows are among the most immediately measurable benefits health plans report. Organisations deploying advanced AI platforms have reduced chart review times from over 40 minutes to under 8 minutes per record, a reduction that transforms the economics of large-scale retrospective programmes.
For health plans wanting to understand how this applies in practice, the detailed breakdown of retrospective HCC coding through RAAPID’s published guidance covers how AI-powered platforms handle chart selection, MEAT evidence capture, two-way coding, and quality assurance within a single automated workflow. The practical impact is a programme that runs faster, costs less, and produces documentation that holds up under audit, without adding headcount.
The two-way coding principle is worth highlighting specifically. Compliance-focused AI platforms flag unsupported HCC codes for deletion with the same rigour they apply to identifying missed diagnoses. This is the approach the OIG’s February 2026 Medicare Advantage compliance guidance explicitly supports. Programmes designed only to add diagnoses represent a regulatory red flag. Accurate risk adjustment means both capturing genuine conditions and removing codes that lack adequate clinical support.
Prospective and Concurrent Integration
AI’s impact on risk adjustment extends well beyond the retrospective review cycle. The most effective health plan programmes in 2026 integrate prospective, concurrent, and retrospective workflows into a unified approach supported by a single platform.
Prospective AI tools integrate directly with EHR systems to support pre-visit planning, surface suspected conditions based on claims history and patient records, and prompt clinical documentation at the point of care where it is most complete and most defensible. Concurrent review tools provide a real-time safety net during and immediately after patient encounters, catching gaps before they require retrospective correction.
This integrated model reduces the downstream volume of records requiring retrospective review, improves the quality of clinical documentation across the entire patient population, and supports the kind of consistent, year-round programme performance that CMS expects from compliant Medicare Advantage organisations.
Building Programmes That Last
The health plans that will navigate 2026 and beyond most successfully are those that treat risk adjustment accuracy as a strategic priority rather than a seasonal project. CMS has confirmed it plans to initiate RADV audits approximately every three months going forward. That cadence means every chart review is potential audit evidence, and the documentation standards applied to retrospective coding need to reflect that reality year-round.
AI does not replace clinical expertise in risk adjustment. It amplifies it. The combination of advanced AI with experienced coders and a compliance-first programme design is what produces the defensible, accurate, and financially sustainable risk adjustment outcomes that modern health plans require.
The technology to achieve this exists now. The regulatory pressure to adopt it is already here.
Written by media@blogmanagement.io
